VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 101 filers reported holding VOYAGER THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 17.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $767,250 | -6.7% | 99,000 | -43.3% | 0.00% | 0.0% |
| Q1 2021 | $822,000 | -39.4% | 174,500 | -8.0% | 0.00% | -25.0% |
| Q4 2020 | $1,356,000 | -33.6% | 189,700 | -0.9% | 0.00% | -42.9% |
| Q3 2020 | $2,043,000 | -58.1% | 191,500 | -50.4% | 0.01% | -30.0% |
| Q2 2020 | $4,876,000 | +2221.9% | 386,400 | +1580.0% | 0.01% | +900.0% |
| Q1 2020 | $210,000 | -30.9% | 23,000 | +5.5% | 0.00% | 0.0% |
| Q4 2019 | $304,000 | -43.7% | 21,800 | -21.2% | 0.00% | -50.0% |
| Q2 2018 | $540,000 | -89.3% | 27,658 | -89.7% | 0.00% | -90.0% |
| Q1 2018 | $5,036,000 | -9.9% | 268,030 | -20.4% | 0.02% | -9.1% |
| Q4 2017 | $5,591,000 | – | 336,807 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 6,391,176 | $45,697,000 | 3.92% |
| ARMISTICE CAPITAL, LLC | 3,392,000 | $24,253,000 | 0.82% |
| Bellevue Group AG | 2,712,083 | $19,391,000 | 0.22% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 141,924 | $1,015,000 | 0.17% |
| XTX MARKETS LLC | 10,578 | $76,000 | 0.16% |
| Aevitas Wealth Management, Inc. | 22,150 | $158,000 | 0.12% |
| Virtus ETF Advisers LLC | 35,079 | $251,000 | 0.10% |
| HITE Hedge Asset Management LLC | 29,357 | $210,000 | 0.05% |
| LINCOLN CAPITAL CORP | 10,000 | $72,000 | 0.05% |
| CIM INVESTMENT MANAGEMENT INC | 18,745 | $134,000 | 0.04% |